ProfessionalLive ClassesNo New Dates

Legislative Horizons in Psychedelic Therapy: What Clinicians Need to Know

This webinar explores the current and emerging U.S. policy environment shaping psychedelic therapy and how clinicians can prepare responsibly for what comes next. It explains how legislation becomes regulation and what uncertainty is common in early-stage programs.

Provider

English

Details

1 Hour

Enrollment

Free
This course is currently marked as no new dates.

Course Overview

This webinar examines the current and emerging policy environment shaping psychedelic therapy in the United States. It focuses on how legislation becomes regulation and the kinds of uncertainty clinicians may encounter as new programs develop. The course is designed for therapists and other clinicians who want to stay informed about policy developments without needing to become policy experts. It emphasizes practical awareness of the legislative landscape and how to think about preparing for change. The content is presented as a webinar and is framed around responsible, informed engagement with a fast-evolving area of practice.

Who is this for?

Therapists and other clinicians interested in the policy and regulatory landscape of psychedelic therapy

Prerequisites

No psychotherapy license requirement is listed on the catalog card.

About the Provider

Fluence is a psychedelic therapy education company offering Professional Certificates and courses for psychedelic therapy, ketamine-assisted psychotherapy, psilocybin facilitation, harm reduction, and integration. Its current public catalog centers on Essentials of Psychedelic Therapy, Introduction to Psychedelic Therapy, and Professional Certificates in Psychedelic Harm Reduction and Integration Therapy, Ketamine-Assisted Psychotherapy, and Psilocybin Facilitation.

View Fluence profile

Course Details

  • PriceFree
  • FormatLive Classes
  • Lifecycle statusNo New Dates
  • Skills
    Legal and ethical practiceClinical practiceHarm ReductionIntegrationFacilitationPsychotherapyKetamine-Assisted TherapyPsilocybin TherapyEthicsInterpreting the path from legislation to regulationRecognizing uncertainty in early-stage programsStaying informed about legislative developmentsPreparing for policy changes in clinical practice
  • Categories